Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
This study has been completed.
Study NCT00157560 Information provided by Massachusetts General Hospital
First Received: September 7, 2005 Last Updated: December 28, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Additional conditions recognized in this trial
Carcinoma
Fallopian Tube Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Fallopian Tube Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Ovarian Diseases
Urogenital Neoplasms
Interventions listed in this trial
Chemotherapy, multiple agents
Sponsors listed in this trial
Massachusetts General Hospital
GlaxoSmithKline
Eli Lilly and Company
Back to top of Main Content
